Jade Biosciences, Inc. (NASDAQ:JBIO) IPO

Jade Biosciences, Inc.

IPO

Went public as Aerovate Therapeutics, Inc. Priced at US$14.00 a share on Jun 29, 2021.

Price
US$14.00 a share
Shares offered
8,682,142 shares of common stock
Offering size
US$121.5 million
Underwriters' option
Up to 1,302,321 more shares
Listing
AVTE on the Nasdaq Global Market
Underwriters
Jefferies, Cowen, Evercore ISI, Wedbush PacGrow · In the order on the cover
Shares delivered
On or about Jul 2, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceMay 6, 2021
Filed publiclyJun 9, 2021
Amended 3 timesNewest Jun 25, 2021
Shares registered with an exchangeJun 25, 2021
Declared effective by the SECJun 29, 2021
Final prospectus, with the priceJun 30, 2021

From the cover of the final prospectus (424B4) filed Jun 30, 2021